Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMITRIPTYLINE\PERPHENAZINE for Dementia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 32 adverse event reports in the FDA FAERS database where AMITRIPTYLINE\PERPHENAZINE was used for Dementia.

Most Reported Side Effects for AMITRIPTYLINE\PERPHENAZINE

Side Effect Reports % Deaths Hosp.
Pain 126 49.0% 0 88
Mobility decreased 120 46.7% 0 94
Balance disorder 99 38.5% 0 93
Fall 98 38.1% 0 94
Cognitive disorder 97 37.7% 0 94
Constipation 97 37.7% 0 94
Blood calcium decreased 96 37.4% 0 93
Creatinine renal clearance decreased 96 37.4% 0 93
Depressed level of consciousness 96 37.4% 0 93
Hypotension 96 37.4% 0 93
Orthostatic hypotension 96 37.4% 0 93
Sedation 96 37.4% 0 93
Toxicity to various agents 96 37.4% 0 92
Sedation complication 89 34.6% 0 89
Off label use 60 23.4% 0 30

Other Indications for AMITRIPTYLINE\PERPHENAZINE

Product used for unknown indication (80) Insomnia (77) Constipation (33) Arthritis (32) Coronary artery disease (32) Duodenal ulcer (32) Fibromyalgia (32) Hypertension (32) Rheumatoid arthritis (31) Angina pectoris (29)

Other Drugs Used for Dementia

DONEPEZIL (1,350) RIVASTIGMINE (887) MEMANTINE (812) PIMAVANSERIN (526) GALANTAMINE (406) QUETIAPINE (366) RISPERIDONE (294) GALANTAMINE HYDROBROMIDE (291) BREXPIPRAZOLE (160) OLANZAPINE (151)

Related Pages

AMITRIPTYLINE\PERPHENAZINE Full Profile All Dementia Drugs AMITRIPTYLINE\PERPHENAZINE Demographics AMITRIPTYLINE\PERPHENAZINE Timeline